科研之友
微信
新浪微博
Facebook
分享链接
摘要
Autologous haematopoietic stem cell transplantation (HSCT) has proved efficacious in treating patients with systemic sclerosis, but different regimens have different associated toxicities and different effects on lung function. Through comparison of different clinical trials, we can learn how to improve the safety of HSCT.
- 出版日期2018-4
- 单位西北大学
